Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China. It offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series; nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine, uridine; and other APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system. The company was founded in 2001 and is based in Xinxiang, China.
Frequently asked questions
What sector does Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) operate in?
Xinxiang Tuoxin Pharmaceutical Co.Ltd. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) current stock price?
As of the latest data, Xinxiang Tuoxin Pharmaceutical Co.Ltd. stock price is CN¥25.95, with a previous close of CN¥25.95.
What is Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) current market capitalization?
Xinxiang Tuoxin Pharmaceutical Co.Ltd. market cap is approximately 3.28 billion.
What is Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) Earnings Per Share (EPS)?
The trailing EPS is -CN¥0.60.
Does Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) pay dividends?
No. Xinxiang Tuoxin Pharmaceutical Co.Ltd. does not pay a dividend.
What is Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) beta (volatility) score?
Xinxiang Tuoxin Pharmaceutical Co.Ltd. has a beta of -0.598, indicating lower volatility than the overall market.